{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1159330",
  "DateCompleted": {
    "Year": "1975",
    "Month": "12",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-1899",
      "JournalIssue": {
        "Volume": "132",
        "Issue": "3",
        "PubDate": {
          "Year": "1975",
          "Month": "Sep"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.",
    "Pagination": {
      "StartPage": "270",
      "EndPage": "275",
      "MedlinePgn": "270-5"
    },
    "Abstract": {
      "AbstractText": [
        "The effect of fever on serum concentrations and urinary excretion of gentamicin sulfate was studied in humans and dogs. Endotoxin-induced fever in dogs resulted in a decrease of approximately 25% in levels of gentamicin in serum 30 and 60 min after intravenous injection of the antibiotic (1.5 mg/kg) when compared with corresponding afebrile values. In six volunteers with etiocholanolone-stimulated fever, serum concentrations of gentamicin was reduced by an average of 40% in all measurements made 1.2, and 3 hr after intramuscular injection (1.5 mg/kg) as compared with afebrile control values in the same subject. Fever was thought to be the principal factor associated with lower levels of gentamicin, although the half-life of gentamicin in serum and renal clearance of the antibiotic were not significantly affected. These findings emphasize the need for frequent measurements of gentamicin in serum as a guide to adjustment of gentamicin treatment in febrile subjects, and perhaps in all patients receiving the antibiotic."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pennington",
        "ForeName": "J E",
        "Initials": "JE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Dale",
        "ForeName": "D C",
        "Initials": "DC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Reynolds",
        "ForeName": "H Y",
        "Initials": "HY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "MacLowry",
        "ForeName": "J D",
        "Initials": "JD"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Gentamicins"
    },
    {
      "RegistryNumber": "97CGB1M48I",
      "NameOfSubstance": "Etiocholanolone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dogs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Etiocholanolone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "blood",
        "metabolism"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "blood",
        "pharmacology"
      ],
      "DescriptorName": "Gentamicins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    }
  ]
}